Exelixis | Aktywa



Current Assets Zmiana Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 28.94B 2.8B 2025-06
Bayer EUR 34.83B 388M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Cytokinetics USD 956.05M 151.89M 2025-03
Eisai JPY 727.66B 33.44B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Exelixis USD 1.18B 215.74M 2025-07
Genmab DKK 4.04B 23.82B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Incyte USD 3.64B 411.91M 2025-06
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 35.5B 3.28B 2025-03
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.64B 86.8M 2025-03
Novartis USD 25.94B 831M 2025-06
Pfizer USD 45.86B 4.5B 2025-03
Sanofi 42.59B 12.51B 2024-12
Takeda JPY 2.51T 8.07B 2025-06
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Xencor USD 521.27M 56.33M 2025-03


Exelixis Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.